TrialJAMA internal medicine2018

Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder: A Randomized Clinical Trial.

Michelle R Lofwall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.